Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ullrich

Showing results (21-30 of 196) with videos related to

Pageof 20
Sort By:
Molecular Imaging|February 5, 2010
Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastomaNorbert Galldiks, Lutz W Kracht, Lothar Burghaus, et al.
European Journal of Radiology|September 19, 2021
Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostateM Boschheidgen, T Ullrich, D Blondin, et al.
Reports on Progress in Physics. Physical Society (Great Britain)|December 8, 2018
The electron-ion collider: assessing the energy dependence of key measurementsE C Aschenauer, S Fazio, J H Lee, et al.
European Radiology|July 9, 2017
Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostateT Ullrich, M Quentin, A K Schmaltz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with gliomaRoland T Ullrich, Lutz Kracht, Anna Brunn, et al.
European Journal of Radiology|September 18, 2022
Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detectionF Ziayee, L Schimmöller, D Blondin, et al.
Cancers|August 26, 2022
EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung CancerCarolin Selenz, Anik Compes, Marieke Nill, et al.
European Radiology|June 28, 2020
Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort studyT Ullrich, C Arsov, M Quentin, et al.
Clinical Radiology|January 7, 2024
Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRIF Ziayee, L Schimmöller, M Boschheidgen, et al.
Abdominal Radiology (New York)|May 16, 2022
Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical marginsM Quentin, L Schimmöller, T Ullrich, et al.
Pageof 20

Showing results (21-30 of 196) with videos related to

Sort By:
Pageof 20
Molecular Imaging|February 5, 2010
Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastomaNorbert Galldiks, Lutz W Kracht, Lothar Burghaus, et al.
European Journal of Radiology|September 19, 2021
Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostateM Boschheidgen, T Ullrich, D Blondin, et al.
Reports on Progress in Physics. Physical Society (Great Britain)|December 8, 2018
The electron-ion collider: assessing the energy dependence of key measurementsE C Aschenauer, S Fazio, J H Lee, et al.
European Radiology|July 9, 2017
Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostateT Ullrich, M Quentin, A K Schmaltz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with gliomaRoland T Ullrich, Lutz Kracht, Anna Brunn, et al.
European Journal of Radiology|September 18, 2022
Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detectionF Ziayee, L Schimmöller, D Blondin, et al.
Cancers|August 26, 2022
EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung CancerCarolin Selenz, Anik Compes, Marieke Nill, et al.
European Radiology|June 28, 2020
Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort studyT Ullrich, C Arsov, M Quentin, et al.
Clinical Radiology|January 7, 2024
Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRIF Ziayee, L Schimmöller, M Boschheidgen, et al.
Abdominal Radiology (New York)|May 16, 2022
Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical marginsM Quentin, L Schimmöller, T Ullrich, et al.
Pageof 20